Neurocrine Bioscience buy Truist Financial Co.
Start price
07.05.26
/
50%
€127.50
Target price
07.05.27
€131.84
Performance (%)
19.18%
Price
11:55
€151.95
Summary
This prediction is currently active. The BUY prediction by Truist_Financial_Co_ currently has a performance of 19.18%. This prediction currently runs until 07.05.27. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Neurocrine Bioscience | -3.752% | -3.752% |
| iShares Core DAX® | -0.097% | 0.537% |
| iShares Nasdaq 100 | 0.585% | -2.390% |
| iShares Nikkei 225® | -0.055% | -2.746% |
| iShares S&P 500 | 0.939% | 1.287% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences (NBIX) had its price target raised by Truist Financial Corporation from $140.00 to $155.00. They now have a "buy" rating on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Truist_Financial_Co_ for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€154.55
13.07.26
13.07.26
€175.50
13.07.27
13.07.27
-1.68%
11:55
11:55
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€107.85
17.02.26
17.02.26
€118.20
17.02.27
17.02.27
40.89%
11:55
11:55
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€116.75
08.01.26
08.01.26
€144.77
08.01.27
08.01.27
30.15%
11:55
11:55
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€119.35
30.10.25
30.10.25
€148.09
30.10.26
30.10.26
27.31%
11:55
11:55